Categories AlphaGraphs, Earnings, Health Care
Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today.
Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales growth was 6.6%.
Net income decreased 12.8% to $4.6 billion while EPS dropped 5.9% to $1.93. Adjusted EPS rose 10.2% to $2.82.
Revenue and earnings beat estimates.
For the full year of 2024, JNJ expects reported sales of $88.0-88.4 billion and adjusted EPS of $9.97-10.07.
The stock was down over 1% in premarket hours on Wednesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DAL Earnings: All you need to know about Delta Air Lines’ Q1 2025 earnings results
Delta Air Lines (NYSE: DAL) reported its first quarter 2025 earnings results today. Operating revenue increased 2% year-over-year to $14 billion. Net income was $240 million, or $0.37 per share,
Deals and R&D in focus as Johnson & Johnson gears up for Q1 earnings
For Johnson & Johnson (NYSE: JNJ), investments in its pipeline and exiting lower priority businesses remain central to its strategy in the new fiscal year. The healthcare behemoth is in
Earnings preview: What to expect when these major banks report Q1 2025 results
The leading players in the banking industry are set to report their earnings results for the first quarter of 2025 over this week and the next. While majors JPMorgan Chase
